Next Generation DNA Sequencing: An Investor Field Guide
Next generation DNA sequencing could set the stage for a new era in medicine given its accuracy, cost-effectiveness, and soon—affordability. In this upcoming webcast, ARK Invest and ETF Trends will highlight developments in sequencing, its impact on healthcare, and how financial advisors can gain exposure to next generation DNA sequencing through a diversified investment approach.
Join Tom Lydon, CEO of ETF Trends, as he moderates a discussion on:
- Next generation DNA sequencing and what it means to the healthcare industry
- Clinical adoption and real-world applications of next generation DNA sequencing
- The growth potential of next generation DNA sequencing
- How financial advisors can gain exposure to next generation DNA sequencing through a diversified investment approach
NOT Accepted for one hour of CFP/CIMA CE credit for live and on-demand attendees
CFA Institute members are encouraged to self-document their continuing professional development activities in their online CE tracker.
Simon BarnettAnalyst, Genomic Revolution
Tom StaudtChief Operating Officer